NCT07643740

Brief Summary

This randomized clinical trial aims to compare the effectiveness of Dry Needling and Neural Mobilization in patients diagnosed with Golfer's Elbow (Medial Epicondylitis). The study will evaluate the effects of both interventions on pain intensity, grip strength, and range of motion. Participants will be randomly allocated to either the Dry Needling group or the Neural Mobilization group and treated over a specified intervention period. Outcome measures will be assessed at baseline and after treatment to determine which intervention provides greater improvement in pain reduction, muscle strength, and functional mobility. The results may contribute to evidence-based rehabilitation strategies for managing Golfer's Elbow

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2026

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

June 8, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

June 8, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

Golfer's elbowMedial EpicondylitisDry needlingNeural mobilisationPainGrip strengthRange of motionPhysiotherapyRehabilitation Sciences

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores represent greater pain intensity.

    Baseline and at 6 weeks post-intervention

Secondary Outcomes (2)

  • Grip strength

    Baseline and at 6 weeks post-intervention

  • Range of motion

    Baseline and at 6 weeks post-intervention

Study Arms (2)

Dry needling

EXPERIMENTAL

Participants will receive dry needling combined with conventional physiotherapy twice weekly for 6 weeks

Procedure: Dry needlingProcedure: Neural mobilization

Neural mobilization

EXPERIMENTAL

Participants will receive neural mobilization combined with conventional physiotherapy twice weekly for 6 weeks

Procedure: Dry needlingProcedure: Neural mobilization

Interventions

Dry needlingPROCEDURE

Participants will receive dry needling to the affected forearm muscles along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion

Dry needlingNeural mobilization

Participants will receive neural mobilization techniques along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion.

Dry needlingNeural mobilization

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both male and female patients were included.
  • Diagnosis of Medial Epicondylitis by spiral test clinically confirmed by orthopaedic.
  • pain is limited on medial epicondyle
  • Pain reproduced with resisted wrist flexion and/or forearm pronation.
  • Aged between 18-40 years
  • Acute to Subacute stage (≥ 6 weeks and ≤ 12 months
  • NPRS score ≥ 4/10 at baseline

You may not qualify if:

  • History of Other elbow pathologies e.g (Lateral epicondylitis , Olecranon bursitis ,Ligament injuries)
  • Radial or ulnar neuropathies not associated with medial epicondylitis.
  • Systemic or inflammatory conditions affecting tendons, such as rheumatoid arthritis
  • Diabetes with neuropathy (unless controlled and neuropathy absent)
  • Previous surgical procedures around the elbow or wrist within the past 6 months
  • Corticosteroid injection, PRP or shockwave therapy within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Green International University

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Elbow TendinopathyPain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

TendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Prof Dr Fahad Tanveer

    Green international University lahore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This study uses single-blind masking. The outcome assessor will be blinded to participants' group allocation to minimize assessment bias. Participants and treating therapists cannot be blinded due to the nature of the interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants with Golfer's Elbow will be randomly allocated into two parallel groups. One group will receive Dry Needling, while the other group will receive Neural Mobilization. Outcomes including pain, grip strength, and range of motion will be assessed at baseline and after completion of the intervention period. The effectiveness of both interventions will be compared between groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 11, 2026

Study Start

January 1, 2025

Primary Completion

March 5, 2026

Study Completion

May 10, 2026

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Due to patients privacy and confidentiality , IPD will not be shared

Locations